Related Experiment Videos
Selenium-Doped Calcium Hydroxide Nanoparticles Inhibit Osteoclasts and Promote Osteogenesis for Osteoporosis
Pengruofeng Liu1, Zimo Zhang2, Minhan Li3,4,5
1Department of Stomatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Purpose:
Osteoporosis is characterized by an acidic and oxidative stress microenvironment driven by excessive osteoclast activity, which impairs osteogenesis and leads to dysregulated bone remodeling. This study aims to develop selenium-doped calcium hydroxide nanoparticles (SeCaNP) to simultaneously inhibit osteoclastogenesis and promote osteogenic differentiation, thereby providing a multi-targeted microenvironment-modulating strategy for osteoporosis therapy.
Methods:
SeCaNP was synthesized via a coprecipitation method and characterized using TEM, XRD, and acid-neutralization assays. In vitro, bone marrow-derived macrophages (BMMs) and bone marrow mesenchymal stem cells (BMSCs) were co-cultured with SeCaNP to assess osteoclast activity and osteogenic differentiation. In vivo, an ovariectomy (OVX)-induced osteoporosis mouse model was established and treated with local injections of SeCaNP. Therapeutic efficacy and biosafety were systematically evaluated.
Results:
SeCaNP significantly upregulated GPx1 expression, effectively scavenged reactive oxygen species (ROS), and neutralized the intracellular acidic microenvironment, thereby markedly inhibiting osteoclastogenesis. Concurrently, SeCaNP promoted BMSC cytoskeletal remodeling and significantly enhanced osteogenic differentiation and mineralization, upregulating key markers (RUNX2, ALP, OPN, OCN). RNA-seq analysis indicated that SeCaNP regulated osteogenesis-related membrane signaling platforms and extracellular matrix assembly. In vivo, SeCaNP treatment significantly ameliorated OVX-induced bone loss, notably improving bone mineral density (BMD) and trabecular microarchitecture parameters (BV/TV, Tb.N, Tb.Th). Furthermore, SeCaNP upregulated BMP-2 expression and serum BALP levels without inducing systemic toxicity.
Conclusion:
SeCaNP effectively overcomes the limitations of conventional osteoporosis therapies by integrating acid neutralization, antioxidant properties, and osteogenic support. Through a dual-regulatory mechanism that inhibits bone resorption and promotes bone formation, SeCaNP successfully reconstructs the pathological bone microenvironment and reverses bone loss, highlighting its significant potential as a microenvironment-modulating biomaterial for anti-osteoporotic therapy.
Related Concept Videos
01:21Skeleton and Calcium Homeostasis
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:40Bone Remodeling
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...